These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 832727)

  • 21. Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections.
    Canto de Cetina TE; Luna MO; Cetina Canto JA; Bassol S
    Contraception; 2004 Feb; 69(2):115-9. PubMed ID: 14759615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
    Draper BH; Morroni C; Hoffman M; Smit J; Beksinska M; Hapgood J; Van der Merwe L
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD005214. PubMed ID: 16856087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutual modification of glucose-stimulated serum insulin responses in female rhesus monkeys by ethinyl estradiol and nortestosterone derivatives.
    Beck P; Venable RL; Hoff DL
    J Clin Endocrinol Metab; 1975 Jul; 41(1):44-53. PubMed ID: 50326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some metabolic effects of long-term use of the injectable contraceptive norethisterone oenanthate.
    Howard G; Blair M; Fotherby K; Trayner I; Hamawi A; Elder MG
    Lancet; 1982 Feb; 1(8269):423-5. PubMed ID: 6121092
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
    Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in plasma lipids caused by oral contraceptives].
    Kaffarnik H
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels.
    Gossain VV; Sherma NK; Michelakis AM; Rovner DR
    Am J Obstet Gynecol; 1983 Nov; 147(6):618-23. PubMed ID: 6356926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbohydrate and lipid studies during six months' treatment with megestrol acetate. Measurements of blood glucose, insulin, growth hormone, and triglycerides.
    Spellacy WN; Newton RE; Buhi WC; Birk SA
    Am J Obstet Gynecol; 1973 Aug; 116(8):1074-8. PubMed ID: 4721135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of lynestrenol and norethindrone on the carbohydrate and lipid metabolism in subjects with gestational diabetes.
    Pyörälä T; Vähäpassi J; Huhtala M
    Ann Chir Gynaecol; 1979; 68(2):69-74. PubMed ID: 507743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
    Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further study on the effect of norethisterone enanthate, an injectable contraceptive on body functions.
    Ali MN; Jalil MA
    Bangladesh Med Res Counc Bull; 1978 Dec; 4(2):63-70. PubMed ID: 575036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammary tumors and serum hormones in the bitch treated with medroxyprogesterone acetate or progesterone for four years.
    Frank DW; Kirton KT; Murchison TE; Quinlan WJ; Coleman ME; Gilbertson TJ; Feenstra ES; Kimball FA
    Fertil Steril; 1979 Mar; 31(3):340-6. PubMed ID: 437169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of growth hormone in the alteration of carbohydrate metabolism induced by oral contraceptive agents.
    Davidson MB; Holzman GB
    J Clin Endocrinol Metab; 1973 Feb; 36(2):246-55. PubMed ID: 4683182
    [No Abstract]   [Full Text] [Related]  

  • 37. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
    Brynhildsen J; Hammar M
    Maturitas; 2005 Apr; 50(4):344-52. PubMed ID: 15780536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of oral contraceptives on carbohydrate metabolism.
    Wynn V; Godsland I
    J Reprod Med; 1986 Sep; 31(9 Suppl):892-7. PubMed ID: 3095547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long acting injectable hormonal contraceptives.
    Fraser IS
    Clin Reprod Fertil; 1982 Mar; 1(1):67-88. PubMed ID: 6226351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injectable contraception.
    Elder MG
    Clin Obstet Gynaecol; 1984 Dec; 11(3):723-41. PubMed ID: 6239732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.